CYP17A1 and polycystic ovary syndrome: Cyp17a1 gene expression was significantly elevated in PCOS ovaries (13.73 ± 5.78 fold), which was significantly reversed after BM-hMSC treatment (1.22 ± 0.20 fold; Fig. 5a).